SA
TEVA icon

Sanctuary Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Sanctuary Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.54M Buy
74,865
+1,341
+2% +$44.7K 0.01% 921
2026
Q1 		$2.21M Buy
73,524
+1,423
+2% +$45.8K 0.01% 915
2025
Q4 		$2.25M Buy
72,101
+104
+0.1% +$2.56K 0.01% 866
2025
Q3 		$1.45M Buy
71,997
+766
+1% +$13.5K 0.01% 1069
2025
Q2 		$1.19M Sell
71,231
-8,831
-11% -$143K 0.01% 1120
2025
Q1 		$1.23M Sell
80,062
-1,581
-2% -$28.2K 0.01% 1031
2024
Q4 		$1.46M Buy
81,643
+46,514
+132% +$846K 0.01% 1040
2024
Q3 		$601K Buy
35,129
+664
+2% +$11.6K ﹤0.01% 1585
2024
Q2 		$476K Buy
+34,465
New +$531K ﹤0.01% 1674

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Sanctuary Advisors's TEVA Position: Q2 2026 in Review

Sanctuary Advisors increased its Teva Pharmaceuticals (TEVA) stake by 1.8% in Q2 2026, buying an estimated $44.7K and bringing the position to 74,865 shares worth $2.54M. The position accounts for 0.01% of the portfolio, ranked #921.

Sanctuary Advisors first reported a position in TEVA in Q2 2024 and has held it in 9 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Sanctuary Advisors held 74,865 shares of Teva Pharmaceuticals worth $2.54M as of Q2 2026.
  • Sanctuary Advisors bought 1,341 Teva Pharmaceuticals shares in Q2 2026, an estimated $44.7K.
  • Teva Pharmaceuticals made up 0.01% of Sanctuary Advisors's portfolio in Q2 2026, its #921 holding.
  • Sanctuary Advisors first reported a position in Teva Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.